NDC 51662-1256
8.4% Sodium Bicarbonate 84 mg per 1 mL injection, solution
On the label: HF Acquisition Co. LLC. DBA HealthFirst. It's repackaged: HF Acquisition Co. LLC. DBA HealthFirst rebottles it from Hospira, Inc.'s NDC 0409-6625.
Where the pills inside were made
| Factory | Where | Role | Last FDA inspection |
|---|---|---|---|
| Hospira, Inc. | Rocky Mount, NC, United States | Makes it, tests it, packages it and labels it | No problems foundFeb 7, 2025 · 11 inspections, 3 with FDA action |
Repackaging site
- HF Acquisition Co LLC, Mukilteo, WA, United States · relabels it
Recalls
- Mar 15, 2019 · Class I · Pfizer Inc.
Presence of Particulate Matter; glass particulates
Lots: Lots: 79-238-EV Exp. 1 July 2019; 79-240-EV Exp. 1 July 2019; 80-088-EV Exp. 1 August 2019 - Jun 15, 2017 · Class II · Hospira a Pfizer Company
Lack of Sterility Assurance
Lots: Lot: 72109EV Exp. 12/01/2018, Lot: 72110EV Exp. 12/01/2018, Lot: 72112EV Exp. 12/01/2018, Lot: 72113EV Exp. 12/01/2018, Lot: 72114EV Exp. 12/01/2018, Lot: 73068EV Exp. 01/01/2019, Lot: 73071EV Exp. 01/01/2019, Lot: 73072EV Exp. 01/01/2019, Lot: 73224EV Exp. 01/01/2019, Lot: 73225EV Exp. 01/01/2019… - Mar 18, 2016 · Class I · Hospira Inc.
Presence of Particulate Matter: particulate matter identified as an insect in one vial.
Lots: Lot # 56-148-EV, Exp 8/1/2017
Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.
Product details
- Generic drug
- Bicarbonate Ion: every company that makes it
- Form
- injection, solution, intravenous
- Strength
- 84 mg per 1 mL
- Approval
- unapproved drug other
- On the market since
- Sep 1, 2018
- Package NDCs
51662-1256-151662-1256-251662-1256-3- Official label
- DailyMed (National Library of Medicine), updated May 3, 2021
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?